|
Bright Prospects for Nitric Oxide Drug Markets
Piribo, the online destination for business intelligence for the biopharma industry, has added a key pharmaceutical intelligence report on the Nitric Oxide market to its collection.
LONDON, UK (PRWEB) October 23, 2004 -- Nitric oxide (NO) is an important agent in drug development, both generating free radicals and scavenging them. It also functions as a signalling molecule and has an important role in the pathogenesis of several diseases. NO-based therapies are particularly important for inflammatory disorders, cardiovascular diseases, erectile dysfunction, inflammation, pain and neuro-protection.
The report Nitric Oxide - Therapeutics, Markets and Companies describes the latest concepts of the role of nitric oxide and analyses the major segments of the market for NO-based drugs and the companies involved in developing them.
The reports author forecasts that the market for drugs where NO is involved in their mechanism of action will rise to $54.4 billion in 2005, up from $30 billion in 2003, and to $96 billion by 2010 as new drugs with NO-based mechanisms are introduced into the market. The report discusses strategies for developing such drugs.
This 212-page report:
•Describes several pharmacological approaches, along with their therapeutic relevance.
•Analyses various approaches using SWOT analysis.
•Compares NO-based therapies with conventional approaches.
•Describes opportunities for combination with modern biotechnology approaches.
•Includes profiles of 37 companies involved in this area, of which 6 are exclusively devoted to NO-based therapeutics.
•Identifies unfulfilled needs in the development of NO-based therapeutics.
•Details important collaborations in the NO market.
Nitric Oxide - Therapeutics, Markets and Companies is available from Piribo. For more information visit http://www.piribo.com/publications/biotechnology/nitric_oxide.html
About Piribo.
Piribo is the source for information products concerning the global biotechnology and pharmaceutical industries and contains details of hundreds of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer a current and comprehensive range of specialised intelligence.
###
|
